NovoLog Mix 50/50 regulatory update

FDA approved an NDA from Novo Nordisk for NovoLog Mix 50/50 to control hyperglycemia in patients with diabetes mellitus. The product is a mixture of 50% insulin aspart protamine suspension and 50% ins...